Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the effects of dietary fiber supplementation on liver fibrosis and glycemic control in patients with Type 2 diabetes and MASLD, finding significant improvements in HbA1c and FIB-4 levels.
The IDEATE study examined the effects of a 5:2 diet and exercise on glycemic control in newly diagnosed type 2 diabetes patients, finding significant improvements in HbA1c levels with the diet.
This study investigated the effects of testosterone therapy on liver fat in men with type 2 diabetes and low testosterone levels, finding a significant reduction in liver fat compared to placebo.
This study evaluated the safety and potential therapeutic effects of orally delivered insulin in patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus, finding significant reductions in liver fat and fibrosis levels.
This study investigated the efficacy of pioglitazone in treating NAFLD patients with abnormal glucose metabolism, revealing significant liver fat content reduction in women compared to men.
This study evaluated the combination therapy of Tofogliflozin and Pioglitazone for treating hepatic steatosis in patients with NAFLD and T2DM, showing significant improvements in various metabolic parameters.
This study investigated the effects of Vildagliptin and Metformin on hepatic steatosis in newly diagnosed Type 2 diabetes patients, showing significant improvements in various metabolic parameters.
The Phase 2b trial evaluated the safety and efficacy of MK-3655 in patients with pre-cirrhotic MASH. Results showed varying rates of MASH resolution and liver fat content reduction across different doses.
The study investigated the effects of combined treatment with pioglitazone and metformin on liver fat in type 2 diabetes patients, finding a significant reduction in liver fat content.
This study evaluated the effects of semaglutide on lipid profiles and liver parameters in patients with type 2 diabetes and obesity, showing significant improvements.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
